Cargando…

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes

Systemic sclerosis (SSc) is an autoinflammatory, fibrotic condition of unknown aetiology. The presence of detectable autoantibodies against diverse nuclear antigens, as well as strong HLA associations with disease, suggest autoimmune involvement, however the links between endogenous and exogenous ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanson, Aimee L., Sahhar, Joanne, Ngian, Gene-Siew, Roddy, Janet, Walker, Jennifer, Stevens, Wendy, Nikpour, Mandana, Assassi, Shervin, Proudman, Susanna, Mayes, Maureen D., Kenna, Tony J., Brown, Matthew A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214260/ https://www.ncbi.nlm.nih.gov/pubmed/35754823 http://dx.doi.org/10.3389/fgene.2022.913196

Ejemplares similares

Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival
por: Morrisroe, Kathleen, et al.
Publicado: (2022)

Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study
por: Osthoff, Michael, et al.
Publicado: (2014)

Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012)

The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis
por: Moxey, Jayne, et al.
Publicado: (2019)

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
por: Fairley, Jessica L., et al.
Publicado: (2023)

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension
por: Tran‐Duy, An, et al.
Publicado: (2021)

The association of low complement with disease activity in systemic sclerosis: a prospective cohort study
por: Esposito, James, et al.
Publicado: (2016)

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis
por: Metwally, Mayada, et al.
Publicado: (2019)

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort
por: Nikpour, Mandana, et al.
Publicado: (2011)

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study
por: Thakkar, Vivek, et al.
Publicado: (2013)

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
por: Hao, Yanjie, et al.
Publicado: (2015)

Determinants of left ventricular structure, filling and long axis function in systemic sclerosis
por: Peverill, Roger E., et al.
Publicado: (2021)

Distribution of HLA-A, -B, and -C Alleles and HLA/KIR Combinations in Han Population in China
por: Shen, Yunsong, et al.
Publicado: (2014)

Cardiovascular disease in systemic sclerosis - an emerging association?
por: Ngian, Gene-Siew, et al.
Publicado: (2011)

Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study
por: Morrisroe, Kathleen, et al.
Publicado: (2016)

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations
por: Hoa, S., et al.
Publicado: (2016)

Profiling of HLA-B Alleles for Association Studies with Ankylosing Spondylitis in the Chinese Population
por: Yi, Lin, et al.
Publicado: (2013)

HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesions
por: Magaret, Amalia, et al.
Publicado: (2016)

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study
por: Thakkar, Vivek, et al.
Publicado: (2012)

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
por: González-Galarza, Faviel F., et al.
Publicado: (2014)

KIR/HLA Interactions and Pathogen Immunity
por: Jamil, Khaleel M., et al.
Publicado: (2011)

Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires
por: Philippon, Camille, et al.
Publicado: (2023)

47XXY and 47XXX in Scleroderma and Myositis
por: Scofield, R. Hal, et al.
Publicado: (2022)

KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy
por: Soria, Alessandro, et al.
Publicado: (2011)

Genetics of scleroderma: implications for personalized medicine?
por: Assassi, Shervin, et al.
Publicado: (2013)

The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients
por: Lenna, Stefania, et al.
Publicado: (2015)

Editorial: Role of HLA and KIR in Viral Infections
por: de Wit, Jelle, et al.
Publicado: (2016)

The role of KIR and HLA interactions in pregnancy complications
por: Colucci, Francesco
Publicado: (2017)

KIR and HLA-C genes in male infertility
por: Wilczyńska, Karolina, et al.
Publicado: (2020)

KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections
por: Qi, Ying, et al.
Publicado: (2006)

Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study
por: Mihai, Carina, et al.
Publicado: (2020)

Significant Association of KIR2DL3-HLA-C1 Combination with Cerebral Malaria and Implications for Co-evolution of KIR and HLA
por: Hirayasu, Kouyuki, et al.
Publicado: (2012)

Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes
por: Acosta-Herrera, Marialbert, et al.
Publicado: (2021)

Activating KIR/HLA complexes in classic Kaposi's Sarcoma
por: Guerini, Franca R, et al.
Publicado: (2012)

Role of HLA, KIR, MICA, and Cytokines Genes in Leprosy
por: Jarduli, Luciana Ribeiro, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kdb77rliaq78ac33m7jakm4mb6